Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MSP Recovery, Inc. (MSPR) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, offering insight into its reimbursement recovery business, technology initiatives, capital structure, and listing status. MSP Recovery describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its filings expand on how this model operates in practice.
Through annual reports on Form 10‑K and quarterly reports on Form 10‑Q, MSP Recovery provides detailed information on its portfolio of assigned healthcare claims, legal strategies under the Medicare Secondary Payer Act and other laws, technology platforms such as LifeWallet and LifeChain, and risk factors related to liquidity, litigation, and regulatory matters. These periodic reports also discuss non‑GAAP measures, impairment assessments of definite‑lived intangible assets, and management’s views on going‑concern considerations.
Current reports on Form 8‑K document material events affecting the company. Recent 8‑Ks describe strategic term sheets with investors such as Hazel Partners and Virage Capital Management, bridge funding and working‑capital facilities, debt‑to‑equity conversions, and amendments to agreements with YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement and related convertible promissory notes. Other 8‑Ks address reverse stock splits implemented to address Nasdaq’s minimum bid‑price rule, confidential settlements with insurers and pharmaceutical defendants, and the settlement of litigation with counterparties such as Cano Health.
Filings under Item 3.01 of Form 8‑K and related disclosures outline Nasdaq listing‑compliance issues, including deficiencies in minimum stockholders’ equity and bid‑price requirements, the company’s submission of a compliance plan, and the subsequent Nasdaq Hearings Panel decision to delist MSP Recovery’s common stock from the Nasdaq Capital Market. The company reports that it expects its common stock to trade on the OTC Markets OTCQB market under the ticker MSPR following suspension from Nasdaq, which is an important consideration for investors tracking trading venues.
Notifications of late filing on Form 12b‑25 (NT 10‑Q) provide context when MSP Recovery is unable to file a quarterly report by the prescribed deadline, such as delays related to a transition to a new independent registered public accounting firm. These notices explain the reasons for the delay and whether the company expects to file within the permitted extension period.
On this page, users can review MSP Recovery’s 10‑K and 10‑Q reports, 8‑K current reports, and other SEC submissions, while AI‑powered tools summarize key sections, highlight significant changes, and call out items such as liquidity discussions, debt and equity arrangements, reverse stock splits, and listing‑status disclosures. This helps readers quickly understand how MSP Recovery’s legal, technological, and financial developments are reflected in its official regulatory record.
MSP Recovery, Inc. filed a prospectus supplement covering up to 285,715 shares of Class A common stock that it may issue and sell to YA II PN, Ltd. (Yorkville) under a standby equity purchase agreement, with Yorkville then eligible to resell those shares from time to time. The Yorkville facility permits equity sales at discounts to market VWAP, subject to a 9.99% ownership cap, while prior stockholder approval has lifted an earlier exchange cap on issuance limits.
The supplement also includes a current report describing a new letter agreement under which Hazel Partners Holdings LLC, the lender under MSP Recovery’s working capital credit facility, made a one-time discretionary advance of $300,000 for operating expenses. The company states this advance does not reinstate or reopen ongoing borrowing capacity, emphasizes that the facility remains fully discretionary with no committed liquidity or borrowing base, and notes it has no rights to, or reasonable basis to expect, further advances from Hazel.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The Public Warrants have a reduced exercise price of $0.4375 per share, while the New Warrants carry a much higher $50,312.50 per share exercise price, which the company states makes exercises unlikely at recent market prices, and it does not expect to rely on New Warrant exercises for cash. As context, on January 21, 2026, the stock closed at $0.067 per share following a 1-for-7 reverse split. Separately, the company discloses a one-time $300,000 advance under its working capital facility with Hazel Partners Holdings LLC, solely for operating expenses, and emphasizes that this is a standalone accommodation with no commitment or reasonable basis to expect further funding.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. These include shares and warrants held by Virage Recovery Master LP, Virage Recovery Participation LP, and Palantir Technologies, Inc., with certain shares issuable upon exercise of warrants at an exercise price of $0.0175 per share, which would yield only nominal proceeds to the company if exercised.
The supplement also attaches a current report describing a new letter agreement with Hazel Partners Holdings LLC, under which Hazel made a one-time $300,000 advance under the existing working capital credit facility to be used solely for operating expenses. The company states this advance is a standalone accommodation, does not restore or expand ongoing availability under the facility, and that it has no rights to, and no reasonable basis to expect, any further advances.
MSP Recovery, Inc. filed a prospectus supplement covering the potential resale, from time to time, of up to 32,220 shares of its Class A common stock by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of
The company also disclosed that Hazel Partners Holdings LLC agreed to make a one-time
MSP Recovery, Inc. entered into a letter agreement with Hazel Partners Holdings LLC on January 19, 2026 for a one-time advance of $300,000 under its existing working capital credit facility. The funds were provided through the facility’s discretionary Operational Collection Floor and may be used solely for operating expenses.
The advance, funded on January 20, 2026, was subject to conditions under the credit agreement, including no default at the time of funding. MSP Recovery explains that this is a standalone accommodation that does not reinstate or expand availability under the working capital facility, which previously had reached approximately $6.0 million of aggregate advances. The company states that no additional funding is currently available under the facility and that it has no rights to, and no reasonable basis to expect, further advances from Hazel, cautioning that this payment should not be viewed as an indication of ongoing liquidity support.
MSP Recovery, Inc. reported that the delisting of its Class A common stock from the Nasdaq Capital Market and move to the OTCQB triggered a technical Event of Default under its convertible promissory notes with Yorkville, tied to a requirement that the stock remain on a “Primary Market.” The default arose when a 10‑trading‑day period ended on January 6, 2026.
The company owes Yorkville about $3.6 million under these Convertible Notes. If the default were fully enforced, MSP Recovery estimates it could have to make accelerated monthly payments of principal and interest of roughly $1.5 million per month until the notes are repaid.
On January 8, 2026, Yorkville agreed in writing to extend the “Primary Market Period” from 10 trading days to 90 calendar days, through March 22, 2026, so long as MSP Recovery’s stock continues to trade on the OTCQB. Yorkville has not issued any acceleration notice, and the company does not believe this technical default has immediately triggered cross‑defaults under other major debts, though it cautions that future defaults or similar waivers are not assured.
MSP Recovery, Inc. entered into a letter agreement with Hazel Partners Holdings LLC under its existing working capital credit facility for a one-time advance of $325,000 to be used solely for operating expenses. This advance, made under the facility’s discretionary Operational Collection Floor, is expected to fund on or before January 9, 2026, subject to conditions including the absence of any default.
The company explains that this $325,000 advance is a standalone accommodation that does not reinstate or reopen any additional availability under the credit facility. Beyond this amount, no further funding is currently available, and the company states it has no rights to, and no reasonable basis to expect, any additional advances. MSP Recovery cautions that this funding should not be viewed as evidence of Hazel’s willingness to provide future liquidity or of the company’s ability to meet operating or debt service obligations beyond this specific advance.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by existing holders. The shares include stock already issued to Virage-affiliated entities and Palantir Technologies, plus shares issuable upon exercise of low-priced warrants at $0.0175 per share, from which the company would receive only nominal proceeds.
The attached current report explains that a Nasdaq Hearings Panel has denied the company’s appeal of prior staff determinations, and the company’s common stock will be delisted from Nasdaq for failing to meet minimum stockholders’ equity of $2.5 million and a $1.00 bid price. Trading of the common stock is expected to continue on the OTCQB market under the ticker “MSPR.” The company also notes a 1-for-7 reverse stock split effective September 1, 2025, and all share figures reflect this split.
MSP Recovery, Inc. has registered for resale up to 32,220 shares of Class A common stock held by existing investors, including 15,239 shares issuable upon exercise of a CPIA Warrant with a per-share exercise price of
The prospectus supplement also incorporates a new report that the company’s common stock will be delisted from Nasdaq after it failed to meet the minimum stockholders’ equity requirement of
MSP Recovery, Inc. updates its shelf prospectus to cover the resale by existing holders of up to 909,982 shares of Class A common stock, 755,200,000 warrants, and the potential issuance of up to 236,019 additional shares upon warrant exercise. The filing explains that Public Warrants, exercisable at $0.4375 per share, would generate less than $500 if fully exercised, while over 1.0 billion New Warrants carry a $50,312.50 per share exercise price and would not provide retained proceeds to the company, so operations are expected to rely on other cash sources. The company also notes a prior 1-for-7 reverse stock split effective September 1, 2025. In the attached current report, MSP Recovery discloses that a Nasdaq Hearings Panel has denied its appeal, and the company’s common stock will be delisted from Nasdaq for not meeting minimum stockholders’ equity of $2.5 million and the $1.00 minimum bid price, with trading expected to continue on the OTCQB market under the symbol “MSPR.”